Chen Yang

Chen Yang

Auto-generated profile, based on publicly available information

Chen Yang

Department of Pathology, Yale School of Medicine, Yale University, New Haven, USA

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 March 2022 in Nature
Verified
Journal Article
Closed access
PDF file
XLXin V. Li
Xin V. Li
ILIrina Leonardi
Irina Leonardi
GPGregory G. Putzel
Gregory G. Putzel
ASAlexa Semon
Alexa Semon
WFWilliam D. Fiers
William D. Fiers
IIIliyan D. Iliev
Iliyan D. Iliev

11 May 2019 in Histopathology
Verified
Journal Article
Closed access
PDF file
IGIván González
Iván González
HLHsiang‐Chih Lu
Hsiang‐Chih Lu
JSJared Sninsky
Jared Sninsky
CYChen Yang
Chen Yang
KBKumar Bishnupuri
Kumar Bishnupuri
DCDeyali Chatterjee
Deyali Chatterjee

25 February 2020 in American Journal of Surgical Pathology
Verified
Journal Article
Closed access
CYChen Yang
Chen Yang
BSBrian Shuch
Brian Shuch
HKHarriet Kluger
Harriet Kluger
PHPeter A. Humphrey
Peter A. Humphrey
AAAdebowale J. Adeniran
Adebowale J. Adeniran
Conflicting data have been published on the prognostic significance of histologic parameters in papillary renal cell carcinoma (PRCC). We conducted a comprehensive evaluation of clinical and histologic parameters in PRCC in nephrectomies and their impact on prognosis, with an emphasis on World Health Organization (WHO)/International Society of Urological Pathology (ISUP) grade, tumor architecture (solid, micropapillary, and hobnail), and PRCC type. A total of 185 PRCC cases were evaluated, 117 (63.2%) type 1, 45 (24.3%) type 2, and 11 (5.9%) mixed type 1 and type 2. Using WHO/ISUP grading criteria, PRCCs were graded as follows: 6 (3.2%) grade 1; 116 (62.7%) grade 2; 61 (33.0%) grade 3; and 2 (1.1%) grade 4. The solid architecture was present in 3 cases (1.6%) and comprised 10%, 10%, and 30% of the tumor area. Micropapillary architecture was present in 10 cases (5.4%), ranging from 5% to 30% of the tumor (mean=11%; median=10%). Hobnail architecture was seen in 9 cases (4.9%), with mean percentage of 23% (median=15%; range: 5% to 50%) involvement of tumor area. Parameters associated with worse disease-free survival (DFS) and overall survival (OS) in the univariate analysis included WHO/ISUP grade, pathologic stage, tumor size, and solid, micropapillary, or hobnail architecture (P<0.05). The pathologic stage and WHO/ISUP grade were significantly associated with both DFS and OS in stepwise multivariate Cox regression analysis (P<0.05). In addition, micropapillary architecture and type 1 histology were linked with an adverse impact on OS (P<0.05). We found no difference in DFS (P=0.8237) and OS (P=0.8222) for type 1 versus type 2 PRCC in our patient cohort. In addition, we performed a meta-analysis with data from studies with reported hazard ratios (HRs) on PRCC type in relation to DFS and OS. We identified 5 studies that reported DFS and found no significant effect for type 2 PRCC (P=0.30; HR=1.43; 95% confidence interval: 0.73-2.80). We identified 7 studies that reported OS and found no significant association between type 2 PRCC and worse OS (P=0.41; HR: 1.21; 95% confidence interval: 0.77-1.91). Our findings suggest that high WHO/ISUP grade and unfavorable architecture (solid, micropapillary, or hobnail), rather than typing of PRCC, are associated with worse outcomes.

1 November 2020 in Kidney International Reports
Verified
Journal Article
Open access
YWYumeng Wen
Yumeng Wen
CYChen Yang
Chen Yang
SMSteven P. Menez
Steven P. Menez
ARAvi Z. Rosenberg
Avi Z. Rosenberg
CPChirag R. Parikh
Chirag R. Parikh
The term “acute tubular injury” (ATI) represents histopathologic renal tubular injury and often manifests clinically as acute kidney injury (AKI). Studies systematically summarizing the clinical presentation and histological changes in human ATI are limited. We used a comprehensive search strategy to search human studies of ATI from 1936 to July 2019. We extracted study characteristics, clinical characteristics, and histologic descriptions of ATI by bright field, immunofluorescence, electron microscopy, and immunohistochemistry. We compared ATI histology as a function of tissue procurement type, timing, and etiologies. We included 292 studies comprising a total of 1987 patients. The majority of studies (222 of 292, 76%) were single-center case reports. The mean age of included patients was 47 years. In native kidney biopsy cases, baseline, peak, and latest creatinine were 1.3 mg/dl, 7.19 mg/dl, and 1.85 mg/dl respectively, and biopsy was performed mostly after peak creatinine (86.7%, 391 of 451). We identified 16 histologic descriptions of tubular injury, including tubular cell sloughing (115 of 292, 39.4%), tubular epithelial flattening/simplification (110 of 292, 37.7%), tubular dilatation (109 of 292, 37.3%), and tubular cell necrosis (93 of 292, 31.8%). There was no difference in tubular injury histology among different tissue procurement types (native kidney biopsy, transplant kidney biopsy, and autopsy), among different etiologies, or between different tissue procurement timing (before or after creatinine peaks in native kidneys). Electron microscopy and immunohistochemistry were used in a minority of studies. ATI manifests with diverse histologic changes. Efforts to establish protocols to harmonize biopsy practices, to handle kidney biopsy for tissue interrogation, and to report results across clinical practice are needed to improve our understanding of this complex disease.

24 June 2020 in Laboratory Investigation
Verified
Journal Article
Closed access
CYChen Yang
Chen Yang
FSFrancisco Sanchez-Vega
Francisco Sanchez-Vega
JCJason C. Chang
Jason C. Chang
WCWalid K. Chatila
Walid K. Chatila
ASAlexander N. Shoushtari
Alexander N. Shoushtari
NRNatasha Rekhtman
Natasha Rekhtman